- The biology of human innate lymphoid cells
- Award date
- 15 April 2016
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
In this thesis I performed studies to investigate the contribution of human innate lymphoid cells (ILCs) in maintaining the mucosal homeostasis, initiating and/or propagating inflammatory responses, but also - when not properly regulated - how these cells contribute to immunopathology.
First I describe a previously unidentified subset of the human ILC family that is enriched in type 1 inflammatory diseases, which we named ILC1. More specifically, I found that ILC1 accumulated in resection specimen from individuals that suffer from Crohn’s disease, and this accumulation inversely correlated with the decrease of ILC3. Mechanistically, I found that ILC1 could derive from ILC3 when exposed to specific inflammatory factors. Furthermore, I observed that the plasticity is a reversible process following inflammatory resolution, and explored their molecular mechanisms underlying this plasticity.
Next, I explored the factors that induce ILC2 activation, as well as the effector molecules that are produced by these cells. In addition I performed gain- and loss-of-function experiments, which revealed the intracellular signalling pathways that are essential for ILC2 effector functions. Finally, I asked the question whether the observed plasticity was restricted to ILC1 and ILC3, or whether ILC2 may also have a reversible transdifferentiation potential towards pro-inflammatory ILC1 when exposed to a type 1 inflammatory environment. To this end, I performed phenotypical and functional studies from resection specimen of individuals that suffer from COPD or polyps from individuals that suffer from allergic chronic rhinosinusitis. Finally, I performed antibody-mediated neutralisation studies in ILC1, ILC2 and ILC3 to explore their potential to manipulate this plasticity.
- Research conducted at: Universiteit van Amsterdam
Thesis (complete) (Embargo until 15 April 2017)
Chapter 5: Interleukin-1β, -4 and -12 control ILC2 fate in human airway inflammation (Embargo until 15 April 2017)
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.